Device
Low-Level Tragus Stimulation
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(1)
Other(1)
Detailed Status
Not yet recruiting2
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
unknown125%
withdrawn125%
not_yet_recruiting250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
The Effect of Low-Level Tragus Stimulation on Inflammation and Early Recurrence After Pulsed Field Ablation: A Randomized Controlled Study
NCT07633431
not_yet_recruitingphase_1
Neuromodulation in Patients With Pulmonary Arterial Hypertension
NCT06802380
withdrawnphase_3
Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions
NCT06110364
unknownnot_applicable
LLTS to Treat Premature Ventricular Contractions
NCT04909528
Clinical Trials (4)
Showing 4 of 4 trials
NCT07633431Not Applicable
The Effect of Low-Level Tragus Stimulation on Inflammation and Early Recurrence After Pulsed Field Ablation: A Randomized Controlled Study
NCT06802380Phase 1
Neuromodulation in Patients With Pulmonary Arterial Hypertension
NCT06110364Phase 3
Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions
NCT04909528Not Applicable
LLTS to Treat Premature Ventricular Contractions
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4